VBI Vaccines Inc (VBIV)
0.58
-0.01
(-1.69%)
USD |
NASDAQ |
Apr 25, 12:15
VBI Vaccines Gross Profit Margin (Quarterly): -245.0% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -245.0% |
| September 30, 2023 | 61.88% |
| June 30, 2023 | -383.8% |
| March 31, 2023 | -633.8% |
| December 31, 2022 | -1.04K% |
| September 30, 2022 | -742.9% |
| June 30, 2022 | -628.9% |
| March 31, 2022 | -2.09K% |
| December 31, 2021 | -3.92K% |
| September 30, 2021 | -2.20K% |
| June 30, 2021 | -1.75K% |
| March 31, 2021 | -701.3% |
| December 31, 2020 | -1.38K% |
| September 30, 2020 | -608.4% |
| June 30, 2020 | -1.02K% |
| March 31, 2020 | -521.0% |
| December 31, 2019 | -350.3% |
| Date | Value |
|---|---|
| September 30, 2019 | -205.6% |
| June 30, 2019 | -267.8% |
| March 31, 2019 | -227.5% |
| December 31, 2018 | 54.25% |
| September 30, 2018 | -209.3% |
| June 30, 2018 | -356.0% |
| March 31, 2018 | -693.8% |
| December 31, 2017 | -510.4% |
| September 30, 2017 | -591.2% |
| June 30, 2017 | -294.5% |
| March 31, 2017 | -903.9% |
| December 31, 2016 | -695.6% |
| September 30, 2016 | -434.2% |
| June 30, 2016 | -757.3% |
| March 31, 2016 | -685.4% |
| December 31, 2015 | |
| September 30, 2015 | -742.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-3.92K%
Minimum
Dec 2021
61.88%
Maximum
Sep 2023
-980.4%
Average
-633.8%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -319.4% |
| Return on Assets | -82.95% |
| Return on Invested Capital | -117.7% |
| Profit Margin (Quarterly) | -1.52% |
| Operating Margin (Quarterly) | -1.45K% |
| Return on Net Operating Assets | -84.55% |